Apoptosis in cancer therapy: Crossing the threshold
- 1 August 1994
- Vol. 78 (4), 539-542
- https://doi.org/10.1016/0092-8674(94)90518-5
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genesNature, 1994
- Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutationsNature Genetics, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Bcl-2 functions in an antioxidant pathway to prevent apoptosisCell, 1993
- Thymocyte apoptosis induced by p53-dependent and independent pathwaysNature, 1993
- No germline TP53 mutations detected in familial and bilateral testicular cancerGenes, Chromosomes and Cancer, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cellsCell, 1992
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Drug-target interactions: only the first step in the commitment to a programmed cell death?British Journal of Cancer, 1991